2002

Sep 10, 2002
Guidant Announces Live Webcast of its Annual Investor/Analyst Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...

Sep 9, 2002
Guidant Announces Completion of Patient Enrollment for Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Presents Significant Opportunity for Preventive Treatment Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 3, 2002
Guidant Announces European Approval to Market Paclitaxel Eluting Stent

Approval Affirms Momentum of Breakthrough Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that the...

Aug 28, 2002
Guidant Updates Investors on the Strength of the Company's Business

Company Raises Third Quarter 2002 Sales and Earnings Per Share Guidance Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Aug 28, 2002
Guidant Announces FDA Clearance and CE Mark of Next Generation Heart Failure Lead Delivery System

New System Enhances Physician''s Ability to Navigate Challenging Anatomy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Show 5102550100 per page
Top